Impact Metrics 2016 - BioRegion of Catalonia

488 views

Published on

Catalonia is the most dynamic bioregion in Spain and one of the most active in Europe. With a population of more than 7.5 millions and territory comparable to Finland, Belgium, the Netherlands and Israel, the BioRegion of Catalonia brings together 734 companies and 89 research organizations, including 41 research centers, 15 university hospitals, 11 universities offering life sciences studies, 13 sciences and technology parks with activity in the life sciences and large research facilities like the Alba-Cells Synchroton and the Barcelona Supercomputing Center (BSC). Barcelona and its metropolitan area are home to 90% of the Catalan life sciences industry.

Published in: Science
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
488
On SlideShare
0
From Embeds
0
Number of Embeds
4
Actions
Shares
0
Downloads
17
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Impact Metrics 2016 - BioRegion of Catalonia

  1. 1. www.biocat.cat BIOREGION OF CATALONIA
  2. 2. CATALONIA WITHALONGINDUSTRIALTRADITION,CATALONIAHAS ADENSEANDINNOVATIVEINDUSTRIALCOMMUNITY •6%OFSPANISHTERRITORY •16%OFPOPULATION(7.5MINHABITANTS) •20%OFGDP •47%OFPHARMACEUTICALINDUSTRY •19.4%OFBIOTECHNOLOGICALINDUSTRY •23%OFINVESTMENTINR&D BARCELONALEADSTHETOP10MAJOR EUROPEANCITIESOFTHEFUTURE2016/2017 CATALONIAISTHEFOURTHREGIONINALLOF EUROPEINTERMSOFFOREIGNINVESTMENT ATTRACTIONIN2015 Sources: Farmaindustria, Asebio, Financial Times' FDI Markets BARCELONA
  3. 3. THEBIOREGIONOFCATALONIA ACOMPETITIVEANDINNOVATIVELIFESCIENCESANDHEALTHCAREECOSYSTEM Catalonia is the most dynamic bioregion in Spain and one of the most active in Europe. With a population of more than 7.5 millions and territory comparable to Finland, Belgium, the Netherlands and Israel, the BioRegion of Catalonia brings together 734 companies and 89 research organizations, including 41 research centers, 15 university hospitals, 11 universities offering life sciences studies, 13 sciences and technology parks with activity in the life sciences and large research facilities like the Alba-Cells Synchroton and the Barcelona Supercomputing Center (BSC). Barcelona and its metropolitan area are home to 90% of the Catalan life sciences industry. BIOCAT BUILDINGNOWWHATTHEECOSYSTEMNEEDSNEXT Biocat has been a strategic player and catalyst in building the Catalan healthcare and life sciences ecosystem. Created in 2006 by the Government of Catalonia and the Barcelona City Council, Biocat is a foundation that boosts public and private stakeholders in the BioRegion (including companies, groups and research organizations, university hospitals, science parks and other support bodies to innovation) in order to transform knowledge and technology into economic growth and social impact.
  4. 4. SINCE2000,CATALONIAHASDEVELOPEDITSOWN SUCCESSFULRESEARCHECOSYSTEM 2000 KEYSUCCESSFACTORS: •Sustainedfundingfrom CatalanGovernment •Researchcentersautonomy •Independentevaluation •Fundingbasedonresults •Highperformanceinattracting EUfunds •Opentalentrecruitment program(ICREA) 2016
  5. 5. Source: Biocat Directory (September 2015) 734 89 COMPANIES RESEARCH ORGANIZATIONS THEBIOREGIONOFCATALONIA,AGROWING ANDINNOVATIVEECOSYSTEM BIOTECH PHARMA MEDTECH (R&D) SUPPLIER & ENGINEERING PROFESSIONAL SERVICES INVESTMENT ENTITIES RESEARCH CENTERS UNIVERSITY HOSPITALS UNIVERSITIES SCIENCE & TECHNOLOGY PARKS TECHNOLOGY CENTERS LARGE FACILITIES 221 46 94 208 139 26 41 15 11 13 7 2 (OUT OF 101 HOSPITALS) (OFFERING LIFE SCIENCES STUDIES)
  6. 6. EMPLOYMENTANDRESOURCES Sources: Biocat Directory (Dec. 2014), Catalan Union of Hospitals, Government of Catalonia and SAVI COMPANIES RESEARCHCENTERS HOSPITALS +5,000RESEARCHERS 8,700WORKERS +89,000WORKERS 5,499RESEARCHERS (EMPLOYEDBYTHEUNIVERSITYHOSPITALS ANDRESEARCHINSTITUTES) (195ESTABLISHMENTS) 42,133 BIOTECH 14,278 PHARMA 9,989 OTHERS 6,622 MEDTECH 11,244 WORKERS COMPANIESHADREVENUESOF 14,369M€ANDCONTRIBUTED WITH7%TOTHEGDP INCATALONIA IN10YEARS,WORKERSINR&DHAVE INCREASED50%ANDRESEARCHERS60%
  7. 7. R&DSPENDINGINCATALONIAREPRESENTS 1.5%OFGDP(2,938M€) 23%OFSPANISHINVESTMENTINR&D Source: Farmaindustria, INE (2014) 355M€ PHARMA INDUSTRY 147M€ BIOTECH COMPANIES 666M€ UNIVERSITIES
  8. 8. ANINTERNATIONALCOMPETITIVER&DSYSTEM Source: Government of Catalonia TOTAL AMOUNT OF UNIVERSITIES WORLDWIDE (APROX.): 30,000 ICIQ 1ST WORLD INSTITUTION IN CHEMISTRY Max Plank Institute (2014) ICFO 1ST WORLD INSTITUTION IN PHYSICS Max Plank Institute (2013) 1 1 UNIVERSITY AMONG THE 49 TOP UNIVERSITIES IN THE WORLD IN SCIENTIFIC PRODUCTION (UB) URAP (2015-2016) 3 3 UNIVERSITIES AMONG THE 50 BEST UNDER 50 YEARS (URV, UAB, UPF) QS TOP-50 UNIVERSITIES UNDER 50 YEARS (2014) 19TH BEST STUDENT CITY OF THE WORLD BARCELONA QS BEST STUDENTS CITIES 2015 2 2 UNIVERSITIES AMONG THE 200 BEST IN THE WORLD (UB, UAB) TIMES HIGHER EDUCATION (2015) CRG 9TH IN THE TOP 100 BEST BIOMEDICAL CENTERS IN THE WORLD Scimago Report (SIR 2013)
  9. 9. 33.4 32.8 22.2 18.2 6.7 ARTICLES PER MILLION INHABITANTS(2008-2012) Source: Government of Catalonia WITHOUT CATALONIA Intermsofpublicationsin Science&Nature,Catalonia doublesinnumberscountries suchasGermanyorFrance RESEARCHERSWORKINGINCATALONIAPUBLISHATLEVELS COMPARABLETOTHOSEOFTHELEADINGEUROPEAN COUNTRIES
  10. 10. CATALONIAPRODUCES3.15%OFALLSCIENTIFICPRODUCTION INEUROPEAND0.99%INTHEWORLD, AND29%OF PUBLICATIONSINSPAIN Source: Scopus / Observatori de la Recerca (OR-IEC), Institut d’Estudis Catalans THENUMBEROFLIFESCIENCES ANDHEALTHCAREPUBLICATIONS ROSE168%FROM2000TO2015 Publications (life sciences) % EU28 % world 20092004 20112006 20102005 20082003200220012000 20122007 2013 2014 2015 4% 5% 2% 3% 1% 0% 10K 12,5K 5K 7,5K 2,5K 0K
  11. 11. THEMORECHALLENGINGANDCOMPETITIVEACALLIS, THEBETTER CATALONIAPERFORMS EUROPEANRESEARCHCOUNCIL(ERC)CALLSARETHEMOSTRESTRICTIVEAMONG EU'SCALLS(LESSTHAN10%APPLICATIONSAREAWARDED) With27grantspermillion inhabitants,Cataloniaranks4th intheEuropeanResearchArea and2ndintheEuropeanUnion COUNTRY ERC GRANTS PER MILLION INHABITANTS (2007-2015) 51.9 46.3 34.5 27.3 23 21.1 18.3 17.9 16.2 17.3 14.8 11.9 11.9 11.0 10.7 10 8.3 9.3 5.8 5.6 5.0 3.7 4.7 3.1 3.0 22.4
  12. 12. H2020FUNDSATTRACTEDTOCATALONIASHOW THECOMPETITIVINESSANDEXCELLENCEOFINSTITUTIONS, COMPANIESANDRESEARCHERS Source: AGAUR from Eurostat 2013 / CORDA 2015 CATALONIAHASATTRACTED73%MOREFUNDSFROMTHEH2020THANTHETWOFIRSTYEARSOFTHEFP7. ThetwofirstyearsofH2020,Cataloniareceived226.8M€.Comparedtoothercountriesfrom theEuropeanResearchArea(ERA)andwithsimilarpopulation,CataloniaovercomesIsraeland Switzerlandinabsolutefigures DENMARK FINLAND AUSTRIA CATALONIA ISRAEL SWITZERLAND 14 20 31 37 41 30 Country Inhabitants (in M) M€ Funding received per population (ratio) DENMARK FINLAND AUSTRIA CATALONIA ISRAEL SWITZERLAND 5.603 5.427 8.489 7.547 7.797 8.037 230.33 119.79 265.73 226.77 154.91 108.67 41 37 31 30 20 14
  13. 13. AWIDERANGEOFCUTTING-EDGEFACILITIESTHATSUPPORT THER&DSYSTEM CENTER FOR GENOMIC REGULATION (CRG) BARCELONA SUPERCOMPUTING CENTER (BSC - CNS) ALBA SYNCHROTRON-CELLS BARCELONA BIOMEDICAL RESEARCH PARK (PRBB) BARCELONA SCIENCE PARK (PCB) ANDBRINGTOGETHER THEPLAYERSOFTHE VALUECHAIN: UNIVERSITIES,RESEARCH CENTERSANDCOMPANIES MORETHAN100PLATFORMS 2LARGEINFRASTRUCTURESOFRESEARCH 13SCIENCEANDTECHNOLOGYPARKS
  14. 14. 5,499RESEARCHERS 8,716EMPLOYEES 780RESEARCHGROUPS WORKINGONLIFE SCIENCES 41RESEARCHCENTERS NEWINITIATIVESANDGROUPINGS2015: Barcelona Institute of Science and TechnologyBIST + +
  15. 15. CATALONIA, THEFOREMOSTREGION INSPAININTERMSOF CLINICALRESEARCH (2004-2011) 11OUTOFTHE TOP20BESTHOSPITALS INSPAINARELOCATED INCATALONIA 1ST POSITIONPERFORMINGCLINICAL TRIALS(27.3%) 15UNIVERSITYHOSPITALSAND 9HOSPITALRESEARCHINSTITUTES Source: Farmaindustria, IASIST (2015)
  16. 16. AHOTSPOTFORBUSINESSANDINNOVATION 7%GDPOFCATALONIA Biotechnology- Therapeutics and diagnostics Supplier & Engineering Investment entities Professional Services and Consulting Biotechnology - Other Pharma Biotechnology - R&D services Medical Technology 734companies 6% 30% 13% 11% 28% 19% 13% 6% 4% Biotech Pharma Medtech Others TURNOVER (M€) COMPANIES 9,9892,910 14,2786,852 11,2443,092 6,6221,514 14,369M€ 42,133(4,000 in R&D) WORKERS Source: Biocat Directory
  17. 17. WHENCOMPARINGNUMBEROFCOMPANIESINEUROPE, CATALONIAISWITHINTHETOP5LEADINGCOUNTRIES DESPITEBEINGAMONGTHE 5SMALLESTCOUNTRIES,CATALONIASTANDS INTHETOP5 INNUMBEROFCOMPANIESINALLSECTORS Permillioninhabitants: - Biotechcompanies: Cataloniastandsin4th positionafterSweden, SwitzerlandandIsrael - Medtechcompanies: Cataloniastandsin4th positionafterIsrael, SwedenandSwitzerland - Pharmacompanies: Cataloniastandsin2nd position,afterBelgium Million Inhabitants 2016 Biotech companies Biotech Therapeutics companies Medtech R&D companies Pharma companiesPer capita Per capita Per capita Per capita AUSTRIA 8.713 94 10.79 40 4.59 52 5.97 15 1.72 BELGIUM 11.338 265 23.37 50 4.41 135 11.91 74 6.53 DENMARK 5.721 137 23.95 58 10.14 71 12.41 10 1.75 FINLAND 5.499 82 14.91 14 2.55 37 6.73 10 1.82 FRANCE 64.574 720 11.15 138 2.14 160 2.48 94 1.46 GERMANY 81.762 1,042 12.74 159 1.94 572 7.00 103 1.26 IRELAND 4.668 65 13.92 18 3.86 39 8.35 11 2.36 ISRAEL 8.377 334 39.87 154 18.38 545 65.06 36 4.30 ITALY 60.617 518 8.55 59 0.97 104 1.72 87 1.44 NETHERLANDS 17.008 409 24.05 86 5.06 117 6.88 40 2.35 NORWAY 5.240 120 22.90 27 5.15 32 6.11 8 1.53 SWEDEN 9.824 408 41.53 115 11.71 301 30.64 41 4.17 SWITZERLAND 8.362 346 41.38 104 12.44 230 27.51 47 5.62 UNITED KINGDOM 65.593 979 14.93 246 3.75 275 4.19 110 1.68 CATALONIA 7.516 221 29.40 45 5.99 94 12.51 46 6.12 Source: Site Selection for Life Sciences Companies in Europe 2015. KPMG & Venture Valuation
  18. 18. ACLUSTERINEXPANSION BETWEEN2013-2015,ONAVERAGE,3NEWCOMPANIESWEREFOUNDEDPERMONTH (THATIS1NEWVENTUREBORNINHEALTHCAREEVERY10DAYS) Source: Biotechegate. Biocat Directory, March 2016. The rest of the slides are based on company figures published at Biocat Report 2015 (September 2015) +100NEW ESTABLISHED COMPANIES FROM2013TO2015 94SPIN-OFFEMERGEDFROM UNIVERSITIES, RESEARCHINSTITUTES ANDHOSPITALS (ACTIVEAT2015) 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 8 25 6 23 8 28 3 24 2 25 3 38 3 35 1 41 40 37 31 3 New companies Inactive
  19. 19. COMPANIESATTRACTEDMORETHAN100M€ ININVESTMENTS(2013-2015) Source: BiotechGate. Biocat Directory: Last updated March 2016. Capital raised by companies legally established at the BioRegion (thus it does not include Palobiopharma nor Sanifit) MAB: Spanish sub-market for smaller, growing companies Direct investment MAB Projected December 2015 and March 2016 2009 201120102008 13.56 10.60 10.50 10.61 11.00 29.50 10.68 18 2.44 55.16 3.62 3.44.31 4.3 2012 2013 2014 2015 2016 60 50 40 30 20 10 0 (inM€)
  20. 20. 87%OFBIOREGIONCOMPANIESARESMEs BIGCOMPANIESAREMAINLYMULTINATIONALPHARMAs Source: Biocat Directory / SABI Overthepasttwoyears(2013-2015) thenumberofmedium-sized companieshasdoubledand accountsfor22%ofallcompanies, whichisasignofprogressive consolidationinthesector Medium-sized <250 ≤€50M ≤€43M Small <50 ≤€10M ≤€10M Micro <10 ≤€2M ≤€2M Company category Employees Balance sheet total Turnover Large companiesMedium-sized companies Small companiesMicro-companies 40% 26% 22% 12% 734companies
  21. 21. 58%OFCOMPANIESARETRADINGTHEIRPRODUCTS ININTERNATIONALMARKETS Source: Biocat Internationalization Survey 2015 THEMAINMARKET FORCATALAN COMPANIESISSPAIN Europeisthemain destinationforexportsand internationalsales(mainly Germany,ItalyandFrance) alongwiththeUnitedStates Collaborations Future entrySales United States Germany United Kingdom Spain Italy France Mexico Brazil China Japan Colombia Canada India Netherlands Australia South Korea Israel Argentina Belgium Sweden 19% 19% 26% 21% 16% 13% 13% 11% 14% 23% 11% 1% 18% 10% 7% 16% 7% 12% 14% 2% 2% 7% 1% 9% 7% 2% 6% 5% 3% 4% 4% 1% 6% 2% 6% 3% 2% 4% 3% 3% 3% 2% 3% 1% 4% 2% 2% 3% 2% 1% 4% 2% 2% 2% 1% 2% 2% 1% 2% 1%
  22. 22. BIOTECH:ACTIVITYOFCOMPANIES Source: Biocat Directory (December 2014) THERAPIES & DIAGNOSTICS R&D SERVICES BIOTECH-OTHER* ACTIVITIES COMPANIES 45 84 92 *Each company may be included into more than one category 2013 2015 0 10%5% 20%15% 30%25% 40%35% 45% Environmental AgBio Industrial Biotechnology Nutraceuticals Cosmetics Food Veterinary Others
  23. 23. BIOTECH&PHARMA:ACTIVITYOFCOMPANIES (WORKINGINTHERAPEUTICAREAS) Source: Biocat Directory Each company can be included in more than one category Generics 20% 18% 15% 10% 10% 9% 9% 8% 5,5% 3% 2% 2% 1% 1% 59% Small molecules Anti-infectives Molecular diagnostics Vaccines Drug delivery Antibodies Peptides Proteins Gene therapy Biosimilars Cell therapy Nucleic acid drugs Stem cells Others 0 20% 40% 60%
  24. 24. BIOTECH&PHARMA:ACTIVITYOFCOMPANIES (OFFERINGSERVICESR&D) Source: Biocat Directory CRO Analytical services Diagnostic services CMO Diagnostic instrumentation Synthesis services Genomics Screening Bioinformatics Proteomics Drug delivery Cell culture Biochips Fill & finish 0 10% 20% 30% 40% 36% 25.5% 15% 14% 13% 12% 11% 7.5% 4% 3% 3% 3% 3% 0.5% Others 29.5% Each company can be included in more than one category
  25. 25. BIOTECH&PHARMA:MAINTHERAPEUTICAREAS Source: Biocat Directory Neoplasms / cancer / oncology Skin and subcutaneous tissue Infectious and parasitic diseases Diseases of the nervous system Respiratory Musculoskeletal system and connective tissue Genitourinary system Cardiovascular Endocrine, nutritional and metabolic diseases Diseases of the blood and blood-forming organs; immune disorders Digestive system Mental and behavioural disorders Diseases of the eye Pregnancy, childbirth and the puerperium Diseases of the ear Injury, poisoning and certain other consequences of external causes External causes of morbidity and mortality Congenital malformations, deformations and chromosomal abnormalities Conditions originating in the perinatal period 0 10% 20% 30% 40% 37% 31% 27.5% 27.5% 22% 20% 20% 20% 19% 16.5% 15% 12% 10% 5% 4% 3% 1.5% 1.5% 1.5% 1.5% Each company can be included in more than one category
  26. 26. MEDTECH:ACTIVITYOFCOMPANIES (WORKINGINR&D,PRODUCTIONANDMARKETINGOFSYSTEMSANDDEVICES FORMEDICALAPPLICATIONSINHUMANSANDANIMALS) Source: Biocat Directory Reusable instruments Dental devices Electro mechanical medical devices Single use devices Non-active implantable devices Anesthetic and respiratory devices Imaging Diagnostic devices Ophthalmic and optical devices Technical aids for disabled persons Diagnostic and therapeutic radiation devices Biomaterials Wound Care Delivery devices Hospital Hardware Coatings Regenerative Medicine Others 0 10% 20% 30% 40% COMPANIESWORKINGINMEDTECH: R&D, PRODUCTION & MKT OF MEDICAL DEVICES SOFTWARE, ELECTRONICS, INSTRUMENTATION OR DISTRIBUTION 94 106 200COMPANIES 19.5% 18% 17.5% 15% 12.5% 9.5% 9% 9% 9% 5% 4.5% 4.5% 2% 2% 2% 1% 1% 37% Each company can be included in more than one category
  27. 27. WORLDWIDEINDUSTRYLEADERSCHOOSETHEBIOREGIONAS THEBESTPLACETOINVESTANDDOBUSINESS BIGMULTINATIONALSANDLOCALBIGPLAYERSESTABLISHEDINTHEBIOREGION BIOTECH&PHARMA MEDTECH
  28. 28. ACCELERATINGPROGRAMSINHEALTHCAREATTHEBIOREGION EMPOWERINGSTART-UPSANDENTREPRENEURSTOSCALEUPTHEIRBUSINESSES PROGRAM/ACCELERATOR CAIXAIMPULSE d·HEALTH BARCELONA HEALTH-U SPIRE BIOVENTURES WHAT IF! BARCELONA GRANTS 4 APP TECH4HEALTH BSTARTUP INCUBIO INSPIRIT LABS KAUTIC40 EMPENTA IQSTECHFACTORY STARTUPBOOTCAMP STARTUP NEXT1 WAYRA LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES LIFE SCIENCES DIGITAL HEALTH DIGITAL HEALTH IT IT IT IT ANY SECTOR ANY SECTOR ANY SECTOR ANY SECTOR ANY SECTOR 6 MONTHS 9 MONTHS 6 MONTHS N/A 8 MONTHS 6 MONTHS 10 MONTHS 6 MONTHS 12 MONTHS N/A 9 MONTHS 5 MONTHS N/A 3 MONTHS 6 WEEKS 12 MONTHS 15 PROJECTS 3-4 PROJECTS 6 START-UPS N/A 10 PROJECTS 4 START-UPS 15 START-UPS 10 START-UPS 7 START-UPS 1-2 PROJECTS 10 PROJECTS 15 PROJECTS N/A 10 START-UPS 10 PROJECTS 10 PROJECTS LA CAIXA BIOCAT SANOFI SPIRE INNOVATION FORUM BAYER HOSPITAL SANT JOAN DE DÉU, ESTEVE, CAIXA CAPITAL RISC, NAE, SHIP2B, DKV BANC DE SABADELL INCUBIO INSPIRIT ORBITAL 40 GENERALITAT DE CATALUNYA, ESADECREÁPOLIS IQS STARTUPBOOTCAMP TECHSTARS TELEFÒNICA INDUSTRY DURATION COHORTSPROMOTERS d·HEALTH BARCELONA 1 Last Startup Next Barcelona edition in April 2016
  29. 29. OURLEADINGTALENT Valenti Fuster, cardiologist Director of Mount Sinai Heart (New York). Editor-in-Chief of the Journal of the American College of Cardiology  (JACC), past President of the  American Heart Association Josep Baselga, oncologist Physician-in-Chief at Memorial Sloan Kettering Cancer Center (New York) Josep M. Gatell, infectious diseases Head of the Infectious Diseases and AIDS Units of the Hospital Clinic of Barcelona  Joan Massagué, oncologist Director of the Sloan-Kettering Institute (New York). Internationally recognized leader in the study of cancer  metastasis and cell behavior Manel Esteller, oncologist Director of the Cancer Epigenetics and Biology Program of the Bellvitge Institute for Biomedical Research (IDIBELL, Barcelona)
  30. 30. SUCCESSSTORIES CATALANFIRMORYZON TORECEIVE21M$FROM ROCHETODEVELOP EPIGENETICSDRUGS
  31. 31. SUCCESSSTORIES THECOMPANY,SPECIALIZEDINDRUGDEVELOPMENTFORRAREORMINORITY DISEASES,GETSMOSTSIGNIFICANTFUNDINGINBIOTECHSECTORINCATALONIA MINORYXTHERAPEUTICSCOMPLETESSERIESAFUNDINGOF19.4M€(21.7M$)
  32. 32. SUCCESSSTORIES REIGJOFREANDNATRACEUTICALAGREETO MERGER,CREATINGFIFTHLARGESTPUBLICLY TRADEDPHARMACEUTICALCOMPANY
  33. 33. SUCCESSSTORIES AELIXTHERAPEUTICS FINISHESSERIESA THERAPEUTICHIV VACCINEFUNDS
  34. 34. SUCCESSSTORIES STAT-DIAGNOSTICA SECURES22.1M$IN SERIESBFINANCING STAT-DIAGNOSTICAANNOUNCES25M€INSERIESCFINANCING
  35. 35. SUCCESSSTORIES MEDTEPCLOSESA 2M$INVESTMENT ANDMOVESTO SANFRANCISCO
  36. 36. SUCCESSSTORIES GALGOMEDICAL RAISES1M€ INFUNDING
  37. 37. More information about the BioRegion of Catalonia at: Biocat Report 2015 http://informe.biocat.cat/en
  38. 38. Follow us: More information about the BioRegion of Catalonia at: Biocat Report 2015 http://informe.biocat.cat/en Silver sponsors:

×